Research ArticleArticle
Use of Serum Clara Cell 16-kDa (CC16) Levels as a Potential Indicator of Active Pulmonary Fibrosis in Systemic Sclerosis
Minoru Hasegawa, Manabu Fujimoto, Yasuhito Hamaguchi, Takashi Matsushita, Katsumi Inoue, Shinichi Sato and Kazuhiko Takehara
The Journal of Rheumatology January 2011, jrheum.100591; DOI: https://doi.org/10.3899/jrheum.100591
Minoru Hasegawa
Manabu Fujimoto
Yasuhito Hamaguchi
Takashi Matsushita
Katsumi Inoue
Shinichi Sato
In this issue
The Journal of Rheumatology
Vol. 51, Issue 3
1 Mar 2024
Use of Serum Clara Cell 16-kDa (CC16) Levels as a Potential Indicator of Active Pulmonary Fibrosis in Systemic Sclerosis
Minoru Hasegawa, Manabu Fujimoto, Yasuhito Hamaguchi, Takashi Matsushita, Katsumi Inoue, Shinichi Sato, Kazuhiko Takehara
The Journal of Rheumatology Jan 2011, jrheum.100591; DOI: 10.3899/jrheum.100591
Use of Serum Clara Cell 16-kDa (CC16) Levels as a Potential Indicator of Active Pulmonary Fibrosis in Systemic Sclerosis
Minoru Hasegawa, Manabu Fujimoto, Yasuhito Hamaguchi, Takashi Matsushita, Katsumi Inoue, Shinichi Sato, Kazuhiko Takehara
The Journal of Rheumatology Jan 2011, jrheum.100591; DOI: 10.3899/jrheum.100591